STEVANATO GROUP S.P.A. Financials Stevanato Group S.p.A.
Equities
STVN
IT0005452658
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.82 USD | +3.41% |
|
-17.50% | -20.04% |
| May. 10 | UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating | MT |
| May. 09 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,227 | 4,445 | 6,583 | 5,546 | - | - |
| Enterprise Value (EV) 2 | 5,037 | 4,445 | 6,583 | 5,752 | 5,894 | 5,640 |
| P/E ratio | 39 x | 31.4 x | 45.5 x | 40.6 x | 32.8 x | 27.1 x |
| Yield | 0.25% | - | - | 0.33% | 0.34% | 0.37% |
| Capitalization / Revenue | 6.19 x | 4.52 x | 6.06 x | 4.91 x | 4.36 x | 3.85 x |
| EV / Revenue | 5.97 x | 4.52 x | 6.06 x | 5.1 x | 4.64 x | 3.91 x |
| EV / EBITDA | 23.1 x | 16.9 x | 22.6 x | 20 x | 17.1 x | 13.9 x |
| EV / FCF | 196,752,246 x | -33,748,195 x | - | - | 114,007,525 x | 39,261,534 x |
| FCF Yield | 0% | -0% | - | - | 0% | 0% |
| Price to Book | 6.16 x | - | - | 3.84 x | 3.62 x | 3.22 x |
| Nbr of stocks (in thousands) | 264,699 | 264,699 | 266,234 | 273,722 | - | - |
| Reference price 3 | 22.45 | 17.97 | 27.29 | 21.82 | 21.82 | 21.82 |
| Announcement Date | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1USD in Million2EUR in Million3USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 843.9 | 983.7 | 1,085 | 1,129 | 1,271 | 1,441 |
| EBITDA 1 | - | 218.3 | 263.6 | 291.5 | 288 | 345.3 | 405.5 |
| EBIT 1 | - | 161.9 | 198.7 | 213 | 196.6 | 236.9 | 288.1 |
| Operating Margin | - | 19.18% | 20.2% | 19.62% | 17.42% | 18.64% | 20% |
| Earnings before Tax (EBT) 1 | - | 165.7 | 187.6 | 189.6 | 187.8 | 240.5 | 296.8 |
| Net income 1 | 78.51 | 134.3 | 143 | 145.7 | 137.1 | 172.4 | 209.7 |
| Net margin | - | 15.91% | 14.54% | 13.42% | 12.14% | 13.56% | 14.55% |
| EPS 2 | 1.071 | 0.5756 | 0.5726 | 0.5996 | 0.5376 | 0.6660 | 0.8063 |
| Free Cash Flow | - | 25.6 | -131.7 | - | - | 51.7 | 143.6 |
| FCF margin | - | 3.03% | -13.39% | - | - | 4.07% | 9.97% |
| FCF Conversion (EBITDA) | - | 11.73% | - | - | - | 14.97% | 35.42% |
| FCF Conversion (Net income) | - | 19.06% | - | - | - | 30% | 68.5% |
| Dividend per Share 2 | - | 0.0555 | - | - | 0.0728 | 0.0748 | 0.0798 |
| Announcement Date | 4/30/21 | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 214.5 | 232.6 | 212.1 | 234.2 | 245.3 | 292.1 | 238 | 255.3 | 271.4 | 320.6 | 236 | 257.6 | 288.6 | 346.9 | 266.9 |
| EBITDA 1 | 51.4 | 58.9 | 54 | 61.8 | 65.8 | 81.9 | 61.9 | 68.2 | 74.7 | 86.7 | 50.6 | 62.17 | 76.46 | 92.41 | - |
| EBIT 1 | 36.5 | 43.8 | 38.8 | 45.9 | 49.1 | 64.8 | 43.6 | 48.7 | 54.2 | 66.6 | 28.9 | 40.23 | 52.26 | 71.57 | 36.95 |
| Operating Margin | 17.02% | 18.83% | 18.29% | 19.6% | 20.02% | 22.18% | 18.32% | 19.08% | 19.97% | 20.77% | 12.25% | 15.62% | 18.11% | 20.63% | 13.84% |
| Earnings before Tax (EBT) 1 | 22.4 | 53.7 | 36.3 | 41.5 | 46 | 63.8 | 36 | 44.3 | 50.4 | 58.8 | 25.7 | 34.5 | 48.7 | 65.45 | - |
| Net income 1 | 18.6 | 44.6 | 27.8 | 30.6 | 36.3 | 48.3 | 28.3 | 34.3 | 37.9 | 45.2 | 18.8 | 26.32 | 36.22 | 51.85 | 25.85 |
| Net margin | 8.67% | 19.17% | 13.11% | 13.07% | 14.8% | 16.54% | 11.89% | 13.44% | 13.96% | 14.1% | 7.97% | 10.22% | 12.55% | 14.95% | 9.69% |
| EPS 2 | 0.0811 | 0.1846 | 0.1053 | 0.1228 | 0.1400 | 0.1909 | 0.1210 | 0.1429 | 0.1485 | 0.1853 | 0.0754 | 0.1065 | 0.1445 | 0.2080 | 0.1020 |
| Dividend per Share 2 | - | 0.0555 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/8/22 | 5/10/22 | 8/4/22 | 11/8/22 | 3/2/23 | 5/4/23 | 7/28/23 | 10/31/23 | 3/7/24 | 5/9/24 | - | - | - | - |
1EUR in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 206 | 349 | 94.3 |
| Net Cash position 1 | - | 190 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | 0.7169 x | 1.009 x | 0.2326 x |
| Free Cash Flow | - | 25.6 | -132 | - | - | 51.7 | 144 |
| ROE (net income / shareholders' equity) | - | 23.3% | - | - | 11.6% | 12.4% | 13% |
| ROA (Net income/ Total Assets) | - | 11.3% | - | - | 5.5% | 6.6% | 7.9% |
| Assets 1 | - | 1,193 | - | - | 2,492 | 2,612 | 2,654 |
| Book Value Per Share 2 | - | 3.640 | - | - | 5.680 | 6.030 | 6.770 |
| Cash Flow per Share 2 | - | 0.5700 | 0.4100 | - | 1.260 | 1.160 | 1.470 |
| Capex 1 | - | 108 | 235 | - | 311 | 276 | 225 |
| Capex / Sales | - | 12.76% | 23.89% | - | 27.53% | 21.75% | 15.6% |
| Announcement Date | 4/30/21 | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
21.82
USD
Average target price
31.41
USD
Spread / Average Target
+43.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.04% | 5.97B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
- Stock Market
- Equities
- STVN Stock
- Financials Stevanato Group S.p.A.
